Kudzu Root (Ge Gen): An In-Depth Analysis of Mechanisms of Action and Therapeutic Applications -

There kudzu root, known in traditional pharmacopoeia under the name of Ge Gen (Pueraria lobata), arouses considerable interest in the contemporary scientific community. This perennial plant from the Fabaceae family, native to East Asia, is no longer relegated to the sole status of an empirical remedy. Thanks to advances in phytochemistry and molecular pharmacology, Ge Gen is positioned as a major subject of study in the search for bioactive compounds with cardiovascular, metabolic and neuroprotective properties. This review of the literature aims to dissect, in the light of the most recent scientific data, the mechanisms of action, the effectiveness and the safety profile of this ancient root.

Ge Gen Phytochemistry: A Multi-Faceted Isoflavone Cocktail

The pharmacological richness of kudzu root lies in its composition of polyphenolic compounds. Isoflavones constitute the major bioactive fraction, with molecules such as daidzein, daidzin, genistein and puerarin . The latter, an isoflavone C glucoside, is considered the gold standard for evaluating the quality of Ge Gen, as its concentration is significant and its biological effects documented. Daidzin, for its part, is an isoflavone 7-O-glucoside glycoside which, through intestinal hydrolysis via β-glucosidases, gives rise to its active aglycone, daidzein. These compounds act synergistically, offering a potentially broader spectrum of therapeutic activities than that of an isolated active ingredient.

Vasodilator Mechanisms of Action at the Cerebral Level

One of the traditional uses of Ge Gen concerns cardiovascular and cerebrovascular conditions. Modern research has elucidated the molecular mechanisms underlying this effect, focusing on the basilar artery, a key vessel in cerebral circulation. A study published in the Journal of Ethnopharmacology highlighted the distinct actions of three major isoflavones.

Signaling Pathways Involved

The in vitro study on rat basilar artery rings demonstrated that daidzein and daidzin induce vasorelaxation via an endothelium-independent pathway. Their action is mainly based on the opening of potassium channels (K+) and the inhibition of calcium influx (Ca2+) in vascular smooth muscle cells. Conversely, the puerarin acts by a mixed mechanism, combining an endothelium-dependent pathway involving the production of nitric oxide (NO) and an independent pathway mediated by K+ channels. These findings suggest that puerarin, daidzein and daidzin may provide therapeutic benefit in obstructive cerebrovascular pathologies by improving blood perfusion.

Metabolic Perspectives: Ge Gen in the Management of Type 2 Diabetes

The antidiabetic potential of Ge Gen is the subject of increasing attention. Classified as a “medicinal and edible herb” in China, kudzu root has an encouraging safety profile, with few side effects reported upon prolonged consumption. This apparent safety paved the way for rigorous clinical trials.

Clinical Trials and Preclinical Data

Several preclinical studies have shown that isoflavones, and particularly puerarin, increase serum insulin concentration, lower blood glucose, and improve insulin resistance in diabetic mouse models. A phase IV, randomized, double-blind, placebo-controlled clinical trial, currently underway, aims to evaluate the efficacy and safety of kudzu root as an adjunct treatment for type 2 diabetes (DT2). The study, scheduled for completion by the end of 2026, follows patients with a glycated hemoglobin (HbA1c) level of between 6.5% and 10.5%. The main objective is to measure the variation in HbA1c level after 12 weeks of treatment with a daily dose of 1.5 g of PLR granules, equivalent to 15 g of raw plant. This research is crucial to scientifically validate the traditional use of Ge Gen in metabolic disorders.

Metabolic Mechanisms of Action and Tissue Distribution

The hypoglycemic effect of puerarin could be linked to its specific tissue distribution. A pharmacokinetic study revealed that after oral administration, puerarin is widely distributed in the body, with particularly high concentrations in the lungs, but also in the kidneys and pancreas. This accumulation at the pancreatic level could partly explain its beneficial impact on insulin secretion and glycemic regulation. Furthermore, research suggests that a diet enriched with puerarin (at concentrations greater than 0.4%) influences the expression and activity of key enzymes of hepatic lipid metabolism, such as fatty acid synthase, AMPK or hormone-sensitive lipase. This regulation could help reduce weight gain, fat accumulation and serum levels of cholesterol and triglycerides, opening perspectives in the prevention of metabolic diseases.

Towards an Application in Gynecology: Ge Gen and Primary Dysmenorrhea

The research also explores the potential of Ge Gen in less conventional therapeutic areas. A recent study looked at the mechanisms of action of Ge-Gen decoction (GGD) in the treatment of primary dysmenorrhea (PDM), particularly the Cold-Moisture Stagnation subtype.

Modulation of the HSP90/AKT/NLRP3 Pathway

Researchers have demonstrated that GGD inhibits the expression of key inflammatory proteins, including HSP90, AKT and the core inflammasome component NLRP3, in an animal model. This inhibition leads to a reduction in the release of pro-inflammatory cytokines like IL-1β and IL-18, thereby alleviating uterine inflammation and pain. Use of an HSP90 agonist partially reversed these effects, confirming that the HSP90/AKT/NLRP3 pathway is a major therapeutic target for GGD. These results suggest that Ge Gen may provide an alternative or complement to nonsteroidal anti-inflammatory drugs (NSAIDs) for some patients, although human clinical trials are needed to confirm these preclinical data.

Toxicological Considerations and Populations at Risk

Despite its centuries-old use and its food-medicine status, the use of kudzu root is not devoid of potential risks, particularly under certain conditions. A safety study, recruitment of which has been completed, specifically focuses on eight risk scenarios in type 2 diabetic patients. These scenarios include:

Taking doses higher than recommended.
Prolonged use.
Patients aged over 80 years.
Pregnant or breastfeeding women.
People with allergies.
Individuals with hepatic or renal insufficiency.

Investigators point out that diabetic patients frequently use herbal supplements without informing their doctors, which can lead to drug interactions or unanticipated side effects. It is therefore imperative to adopt a cautious approach and consult a healthcare professional before considering Ge Gen supplementation, especially since some studies mention contraindications, particularly in the case of a family history of breast cancer, due to its phytoestrogenic properties.

Conclusion and Outlook

There kudzu root (Ge Gen) is much more than just a traditional medicinal plant. Modern scientific data, from molecular pharmacology and rigorous clinical trials, confirm and clarify its therapeutic properties. From cerebral vasodilator effects to the regulation of carbohydrate and lipid metabolism, including the modulation of inflammation, the isoflavones it contains – and first and foremost the puerarin – act on specific molecular targets. Ongoing clinical trials, particularly on type 2 diabetes, could provide solid evidence of its effectiveness as an adjunctive treatment, thus contributing to better integration of herbal medicine into contemporary medical practice.

Kudzu Root (Ge Gen): An In-Depth Analysis of Mechanisms of Action and Therapeutic Applications